Related Experiment Video

Updated: Jul 8, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Respiratory infections: pneumonia, lung abscess, and empyema

Pramod S Puligandla1, Jean-Martin Laberge

  • 1Divisions of Pediatric Surgery and Pediatric Critical Care Medicine, The Montreal Children's Hospital, McGill University Health Center, Montreal, Quebec, Canada. pramod.puligandla@muhc.mcgill.ca

Seminars in Pediatric Surgery
|December 26, 2007
PubMed

Insights

Childhood pneumonia requires hospitalization in some cases, especially for immunocompromised children. This review covers pneumonia

Area of Science:

  • Pediatric infectious diseases
  • Pulmonology
  • Immunocompromised host infections

Background:

  • Pneumonia is a significant cause of illness and death in children.
  • While often managed outpatient, some children require hospitalization.
  • Immunocompromised children are at higher risk for severe respiratory infections.

Purpose of the Study:

  • To review the clinical presentation, causes, and treatment of childhood pneumonia.
  • To specifically address pneumonia in immunocompromised children.
  • To discuss complications like lung abscess and empyema.

Main Methods:

  • Literature review focusing on childhood pneumonia.
  • Emphasis on clinical aspects, etiology, and therapeutic strategies.
  • Specific consideration of the immunocompromised pediatric population.

Main Results:

  • Pneumonia presents varied clinical features across age groups.
  • Etiology differs based on age and immune status.
  • Treatment protocols vary, with special attention to immunocompromised patients.

Conclusions:

  • Childhood pneumonia remains a critical issue, particularly in immunocompromised children.
  • Prompt diagnosis and tailored treatment are essential for favorable outcomes.
  • Awareness of potential complications like lung abscess and empyema is crucial.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...